OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase II Trial of Amsacrine Plus Intermediate-dose Ara-C (IDAC) with or without Etoposide as Salvage Therapy for Refractory or Relapsed Acute Leukemia

HTML

Year: 2005
Type: article
Study design: Clinical Trial
Source: Japanese Journal of Clinical Oncology
DOI: 10.1093/jjco/hyi149
Authors: Woo Jin Sung, Dong Hwan Kim, Sang Kyun Sohn, Jong Gwang Kim, Jin Ho Baek, Seok Bong Jeon, Joon Ho Moon, Byung Min Ahn, Kyu Bo Lee
Institution: Kyungpook National University Hospital
Language: English

Topic: Acute Myeloid Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: amsacrine, intermediate-dose cytarabine, etoposide, salvage therapy, refractory acute leukemia, relapsed acute leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, complete remission, overall survival, heart failure, central nervous system toxicity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2140191908
FWCI: 0.767
Cites: 24
Cited by: 21
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms